Skip to main content
. 2026 Mar 26;16(7):998. doi: 10.3390/diagnostics16070998
NAC Neoadjuvant chemotherapy
nMBC Non-metastatic breast cancer
NPAR Neutrophil percentage-to-albumin ratio
pCR Pathologic complete response
OS Overall survival
DFS Disease-free survival
NHANES National Health and Nutrition Examination Survey
ER Estrogen receptor
PR Progesterone receptor
HER2 Human epidermal growth factor receptor 2
AJCC The American Joint Committee on Cancer
PNI Perineural invasion
LVI Lymphovascular invasion
ECE Extracapsular extension